Literature DB >> 16228159

[Glycogenesis Type II (M. Pompe). Selective failure of the respiratory musculature--a rare first symptom].

L Burghaus1, W Liu, E Neuen-Jacob, K Gempel, W F Haupt.   

Abstract

Late-onset Pompe's disease, a generalized lysosomal glycogen storage disease caused by acid maltase deficiency, usually presents as a slowly progressive muscular weakness of proximal muscles in lower limbs, followed by involvement of respiratory muscles. In the case presented here, however, respiratory failure was the first and selective symptom which caused the uncommon appearance of a patient entering our outpatient clinic on foot carrying his own artificial respirator. Intercostal muscle biopsy eventually led to the diagnosis.

Entities:  

Mesh:

Year:  2006        PMID: 16228159     DOI: 10.1007/s00115-005-2005-7

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  9 in total

1.  [Diagnosis and differential diagnosis of lysosomal glycogen storage disease].

Authors:  D Fischer; S Paus; R Schröder
Journal:  Nervenarzt       Date:  2003-10       Impact factor: 1.214

2.  Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue.

Authors:  C DE DUVE; B C PRESSMAN; R GIANETTO; R WATTIAUX; F APPELMANS
Journal:  Biochem J       Date:  1955-08       Impact factor: 3.857

3.  Localization and ordering of acid alpha-glucosidase (GAA) and thymidine kinase (TK1) by fluorescence in situ hybridization.

Authors:  W L Kuo; R Hirschhorn; M L Huie; K Hirschhorn
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

4.  Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients.

Authors:  M L C Hagemans; L P F Winkel; P A Van Doorn; W J C Hop; M C B Loonen; A J J Reuser; A T Van der Ploeg
Journal:  Brain       Date:  2005-01-19       Impact factor: 13.501

5.  Sleep-disordered breathing and respiratory failure in acid maltase deficiency.

Authors:  U Mellies; R Ragette; C Schwake; M Baethmann; T Voit; H Teschler
Journal:  Neurology       Date:  2001-10-09       Impact factor: 9.910

Review 6.  [Myopathy in the adult form of glycogenosis II. Two case reports and review of the literature].

Authors:  S Horstmann; C Meier; M Mumenthaler; R Gitzelmann
Journal:  Fortschr Neurol Psychiatr       Date:  1990-09       Impact factor: 0.752

Review 7.  Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease).

Authors:  Nina Raben; Paul Plotz; Barry J Byrne
Journal:  Curr Mol Med       Date:  2002-03       Impact factor: 2.222

8.  alpha-Glucosidase deficiency in generalized glycogenstorage disease (Pompe's disease).

Authors:  H G HERS
Journal:  Biochem J       Date:  1963-01       Impact factor: 3.857

Review 9.  Pompe disease in infants and children.

Authors:  Priya Sunil Kishnani; R Rodney Howell
Journal:  J Pediatr       Date:  2004-05       Impact factor: 4.406

  9 in total
  8 in total

1.  Spinal delivery of AAV vector restores enzyme activity and increases ventilation in Pompe mice.

Authors:  Kai Qiu; Darin J Falk; Paul J Reier; Barry J Byrne; David D Fuller
Journal:  Mol Ther       Date:  2011-10-18       Impact factor: 11.454

2.  Stimulation of Respiratory Motor Output and Ventilation in a Murine Model of Pompe Disease by Ampakines.

Authors:  Mai K ElMallah; Silvia Pagliardini; Sara M Turner; Anthony J Cerreta; Darin J Falk; Barry J Byrne; John J Greer; David D Fuller
Journal:  Am J Respir Cell Mol Biol       Date:  2015-09       Impact factor: 6.914

3.  Respiratory function in late-onset Pompe disease patients receiving long-term enzyme replacement therapy for more than 48 months.

Authors:  Ilka Schneider; Frank Hanisch; Tobias Müller; Bernd Schmidt; Stephan Zierz
Journal:  Wien Med Wochenschr       Date:  2012-11-19

Review 4.  The respiratory neuromuscular system in Pompe disease.

Authors:  David D Fuller; Mai K ElMallah; Barbara K Smith; Manuela Corti; Lee Ann Lawson; Darin J Falk; Barry J Byrne
Journal:  Respir Physiol Neurobiol       Date:  2013-06-21       Impact factor: 1.931

5.  Pompe's Disease in Childhood: A Metabolic Myopathy.

Authors:  U Raju; S C Shaw; K S Rana; M Sharma; H R Ramamurthy
Journal:  Med J Armed Forces India       Date:  2011-07-21

6.  Neuropathology in respiratory-related motoneurons in young Pompe (Gaa(-/-)) mice.

Authors:  Sara M F Turner; Aaron K Hoyt; Mai K ElMallah; Darin J Falk; Barry J Byrne; David D Fuller
Journal:  Respir Physiol Neurobiol       Date:  2016-02-26       Impact factor: 1.931

7.  Hypoglossal neuropathology and respiratory activity in pompe mice.

Authors:  Kun-Ze Lee; Kai Qiu; Milapjit S Sandhu; Mai K Elmallah; Darin J Falk; Michael A Lane; Paul J Reier; Barry J Byrne; David D Fuller
Journal:  Front Physiol       Date:  2011-06-30       Impact factor: 4.566

8.  Clinical Analysis of Algerian Patients with Pompe Disease.

Authors:  Y Sifi; M Medjroubi; R Froissart; N Taghane; K Sifi; A Benhabiles; S Lemai; S Semra; H Benmekhebi; Z Bouderda; N Abadi; A Hamri
Journal:  J Neurodegener Dis       Date:  2017-02-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.